StemCell Technologies Obtains License For Inner Ear Organoid Technology.
VANCOUVER, B.C., March 7, 2018 -- StemCell Technologies has signed an exclusive license with Indiana University for patented rights to inner ear organoid technologies.
The inner ear contains organs responsible for detecting sounds and maintaining balance, both of which are mediated by a sensory cell called the hair cell due to its specialized protrusions resembling tiny hairs.
Hair cell dysfunction can result in many types of hearing and balance problems. Further, these cells in humans have limited abilities to regenerate and are very inaccessible for scientists to study.
Eri Hashino and Karl Koehler, however, have derived methods for generating inner ear organoids from pluripotent stem cells in a dish. These organoids offer a renewable source to generate functional hair cells useful for many applications from basic research to drug screening.
CEO Allen Eaves said the company expects to develop products from this license that enable scientists to have access to sensory cells in sufficient quantities needed to develop therapeutic cures for hearing and balance disorders.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Technology Licensing|
|Publication:||Stem Cell Business News|
|Date:||Mar 19, 2018|
|Previous Article:||Caladrius Acquires License To Late Stage CD34+ Cell Therapy For Refractory Angina.|
|Next Article:||Finance Company Loans Mesoblast $75 Million.|